Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Labcorp Holdings Inc. (NYSE:LH ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT Company Participants Adam Schechter - President, CEO & Chairman Julia Wang - CFO & Executive VP Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good morning, everyone. I'm Erin Wright, health care services analyst at Morgan Stanley.
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH ) Q2 2025 Earnings Conference Call July 24, 2025 9:00 AM ET Company Participants Adam H. Schechter - President, CEO & Chairman Christin O'Donnell - Vice President of Investor Relations Julia A.
Labcorp (LH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
